Cryptococcal meningoencephalitis associated with the long-term use of ruxolitinib

被引:0
作者
Chih-Cheng Chen
Yi-Yang Chen
Cih-En Huang
机构
[1] Chang Gung Memorial Hospital,Division of Hematology and Oncology, Department of Medicine
[2] Chang Gung University,College of Medicine
来源
Annals of Hematology | 2016年 / 95卷
关键词
Cryptococcus; Meningitis; Myeloproliferative neoplasm; Ruxolitinib; Myelofibrosis; HIV-seronegative;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:361 / 362
页数:1
相关论文
共 31 条
[1]  
Harrison C(2012)JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis N Engl J Med 366 787-798
[2]  
Kiladjian JJ(2012)A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis N Engl J Med 366 799-807
[3]  
Al-Ali HK(2013)Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis? Blood 122 3843-3844
[4]  
Verstovsek S(2014)Hepatitis B virus reactivation associated with ruxolitinib Ann Hematol 93 1075-1076
[5]  
Mesa RA(2013)Progressive multifocal leukoencephalopathy associated with ruxolitinib N Engl J Med 369 197-198
[6]  
Gotlib J(2013)Bilateral toxoplasmosis retinitis associated with ruxolitinib N Engl J Med 369 681-683
[7]  
Heine A(2013)An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor Chest 143 1478-1479
[8]  
Brossart P(2013)JAKs and STATs in immunity, immunodeficiency, and cancer N Engl J Med 368 161-170
[9]  
Wolf D(2013)The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo Blood 122 1192-1202
[10]  
Shen CH(2015)JAK inhibition impairs NK cell function in myeloproliferative neoplasms Cancer Res 75 2187-2199